 | • レポートコード：MRC2-11QY08800 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は小児用医薬品・ワクチンのグローバル市場について調査・分析したレポートです。種類別（ジフテリア、インフルエンザ、肝炎、肺炎球菌性疾患、髄膜炎菌性疾患、おたふく風邪、その他）市場規模、用途別（新生児、乳幼児、子供）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別小児用医薬品・ワクチンの競争状況、市場シェア ・世界の小児用医薬品・ワクチン市場：種類別市場規模 2015年-2020年（ジフテリア、インフルエンザ、肝炎、肺炎球菌性疾患、髄膜炎菌性疾患、おたふく風邪、その他） ・世界の小児用医薬品・ワクチン市場：種類別市場規模予測 2021年-2026年（ジフテリア、インフルエンザ、肝炎、肺炎球菌性疾患、髄膜炎菌性疾患、おたふく風邪、その他） ・世界の小児用医薬品・ワクチン市場：用途別市場規模 2015年-2020年（新生児、乳幼児、子供） ・世界の小児用医薬品・ワクチン市場：用途別市場規模予測 2021年-2026年（新生児、乳幼児、子供） ・北米の小児用医薬品・ワクチン市場分析：米国、カナダ ・ヨーロッパの小児用医薬品・ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの小児用医薬品・ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の小児用医薬品・ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの小児用医薬品・ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Merck & Co., Inc. (USA)、Abbott Laboratories (USA)、Amgen, Inc. (USA)、Eli Lilly and Company (USA)、F. Hoffmann-La Roche Ltd (Switzerland)、Genentech, Inc. (USA)、GlaxoSmithKline plc. (UK)、Janssen Biologics B.V. (USA)、Actelion Pharmaceuticals、AstraZeneca Plc. (UK)、Boehringer Ingelheim GmbH (Germany)、Bristol-Myers Squibb Company (USA)、Allergan, Inc. (USA)、Novartis AG (Switzerland)、Novo Nordisk A/S (Denmark)、Pfizer, Inc. (USA)、Sanofi S.A (France)、Shionogi Inc. (USA)、Takeda ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child’s age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.
Market Analysis and Insights: Global Pediatric Drugs and Vaccines Market
The global Pediatric Drugs and Vaccines market size is projected to reach US$ 104980 million by 2026, from US$ 95480 million in 2020, at a CAGR of 9.0%% during 2021-2026.
Global Pediatric Drugs and Vaccines Scope and Market Size
Pediatric Drugs and Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Drugs and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pediatric Drugs and Vaccines market is segmented into
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Segment by Application, the Pediatric Drugs and Vaccines market is segmented into
Newborn
Infant
Child
Regional and Country-level Analysis
The Pediatric Drugs and Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pediatric Drugs and Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pediatric Drugs and Vaccines Market Share Analysis
Pediatric Drugs and Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pediatric Drugs and Vaccines business, the date to enter into the Pediatric Drugs and Vaccines market, Pediatric Drugs and Vaccines product introduction, recent developments, etc.
The major vendors covered:
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
1 Study Coverage
1.1 Pediatric Drugs and Vaccines Product Introduction
1.2 Market Segments
1.3 Key Pediatric Drugs and Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type
1.4.2 Diphtheria
1.4.3 Influenza
1.4.4 Hepatitis
1.4.5 Pneumococcal Diseases
1.4.6 Meningococcal Diseases
1.4.7 Mumps
1.4.8 Others
1.5 Market by Application
1.5.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Application
1.5.2 Newborn
1.5.3 Infant
1.5.4 Child
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pediatric Drugs and Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Pediatric Drugs and Vaccines Revenue 2015-2026
2.1.2 Global Pediatric Drugs and Vaccines Sales 2015-2026
2.2 Global Pediatric Drugs and Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Pediatric Drugs and Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pediatric Drugs and Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pediatric Drugs and Vaccines Competitor Landscape by Players
3.1 Pediatric Drugs and Vaccines Sales by Manufacturers
3.1.1 Pediatric Drugs and Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Pediatric Drugs and Vaccines Revenue by Manufacturers
3.2.1 Pediatric Drugs and Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pediatric Drugs and Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pediatric Drugs and Vaccines Revenue in 2019
3.2.5 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pediatric Drugs and Vaccines Price by Manufacturers
3.4 Pediatric Drugs and Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Pediatric Drugs and Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pediatric Drugs and Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Pediatric Drugs and Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pediatric Drugs and Vaccines Market Size by Type (2015-2020)
4.1.1 Global Pediatric Drugs and Vaccines Sales by Type (2015-2020)
4.1.2 Global Pediatric Drugs and Vaccines Revenue by Type (2015-2020)
4.1.3 Pediatric Drugs and Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pediatric Drugs and Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Pediatric Drugs and Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pediatric Drugs and Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pediatric Drugs and Vaccines Market Size by Application (2015-2020)
5.1.1 Global Pediatric Drugs and Vaccines Sales by Application (2015-2020)
5.1.2 Global Pediatric Drugs and Vaccines Revenue by Application (2015-2020)
5.1.3 Pediatric Drugs and Vaccines Price by Application (2015-2020)
5.2 Pediatric Drugs and Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Pediatric Drugs and Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Pediatric Drugs and Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pediatric Drugs and Vaccines by Country
6.1.1 North America Pediatric Drugs and Vaccines Sales by Country
6.1.2 North America Pediatric Drugs and Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pediatric Drugs and Vaccines Market Facts & Figures by Type
6.3 North America Pediatric Drugs and Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Pediatric Drugs and Vaccines by Country
7.1.1 Europe Pediatric Drugs and Vaccines Sales by Country
7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pediatric Drugs and Vaccines Market Facts & Figures by Type
7.3 Europe Pediatric Drugs and Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pediatric Drugs and Vaccines by Region
8.1.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Region
8.1.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pediatric Drugs and Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Pediatric Drugs and Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pediatric Drugs and Vaccines by Country
9.1.1 Latin America Pediatric Drugs and Vaccines Sales by Country
9.1.2 Latin America Pediatric Drugs and Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pediatric Drugs and Vaccines Market Facts & Figures by Type
9.3 Central & South America Pediatric Drugs and Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pediatric Drugs and Vaccines by Country
10.1.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Country
10.1.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pediatric Drugs and Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Pediatric Drugs and Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Merck & Co., Inc. (USA)
11.1.1 Merck & Co., Inc. (USA) Corporation Information
11.1.2 Merck & Co., Inc. (USA) Description and Business Overview
11.1.3 Merck & Co., Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
11.1.5 Merck & Co., Inc. (USA) Related Developments
11.2 Abbott Laboratories (USA)
11.2.1 Abbott Laboratories (USA) Corporation Information
11.2.2 Abbott Laboratories (USA) Description and Business Overview
11.2.3 Abbott Laboratories (USA) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Products Offered
11.2.5 Abbott Laboratories (USA) Related Developments
11.3 Amgen, Inc. (USA)
11.3.1 Amgen, Inc. (USA) Corporation Information
11.3.2 Amgen, Inc. (USA) Description and Business Overview
11.3.3 Amgen, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
11.3.5 Amgen, Inc. (USA) Related Developments
11.4 Eli Lilly and Company (USA)
11.4.1 Eli Lilly and Company (USA) Corporation Information
11.4.2 Eli Lilly and Company (USA) Description and Business Overview
11.4.3 Eli Lilly and Company (USA) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Products Offered
11.4.5 Eli Lilly and Company (USA) Related Developments
11.5 F. Hoffmann-La Roche Ltd (Switzerland)
11.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
11.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Description and Business Overview
11.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Products Offered
11.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Related Developments
11.6 Genentech, Inc. (USA)
11.6.1 Genentech, Inc. (USA) Corporation Information
11.6.2 Genentech, Inc. (USA) Description and Business Overview
11.6.3 Genentech, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Products Offered
11.6.5 Genentech, Inc. (USA) Related Developments
11.7 GlaxoSmithKline plc. (UK)
11.7.1 GlaxoSmithKline plc. (UK) Corporation Information
11.7.2 GlaxoSmithKline plc. (UK) Description and Business Overview
11.7.3 GlaxoSmithKline plc. (UK) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Products Offered
11.7.5 GlaxoSmithKline plc. (UK) Related Developments
11.8 Janssen Biologics B.V. (USA)
11.8.1 Janssen Biologics B.V. (USA) Corporation Information
11.8.2 Janssen Biologics B.V. (USA) Description and Business Overview
11.8.3 Janssen Biologics B.V. (USA) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Products Offered
11.8.5 Janssen Biologics B.V. (USA) Related Developments
11.9 Actelion Pharmaceuticals
11.9.1 Actelion Pharmaceuticals Corporation Information
11.9.2 Actelion Pharmaceuticals Description and Business Overview
11.9.3 Actelion Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Products Offered
11.9.5 Actelion Pharmaceuticals Related Developments
11.10 AstraZeneca Plc. (UK)
11.10.1 AstraZeneca Plc. (UK) Corporation Information
11.10.2 AstraZeneca Plc. (UK) Description and Business Overview
11.10.3 AstraZeneca Plc. (UK) Sales, Revenue and Gross Margin (2015-2020)
11.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Products Offered
11.10.5 AstraZeneca Plc. (UK) Related Developments
11.1 Merck & Co., Inc. (USA)
11.1.1 Merck & Co., Inc. (USA) Corporation Information
11.1.2 Merck & Co., Inc. (USA) Description and Business Overview
11.1.3 Merck & Co., Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Products Offered
11.1.5 Merck & Co., Inc. (USA) Related Developments
11.12 Bristol-Myers Squibb Company (USA)
11.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
11.12.2 Bristol-Myers Squibb Company (USA) Description and Business Overview
11.12.3 Bristol-Myers Squibb Company (USA) Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Bristol-Myers Squibb Company (USA) Products Offered
11.12.5 Bristol-Myers Squibb Company (USA) Related Developments
11.13 Allergan, Inc. (USA)
11.13.1 Allergan, Inc. (USA) Corporation Information
11.13.2 Allergan, Inc. (USA) Description and Business Overview
11.13.3 Allergan, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Allergan, Inc. (USA) Products Offered
11.13.5 Allergan, Inc. (USA) Related Developments
11.14 Novartis AG (Switzerland)
11.14.1 Novartis AG (Switzerland) Corporation Information
11.14.2 Novartis AG (Switzerland) Description and Business Overview
11.14.3 Novartis AG (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Novartis AG (Switzerland) Products Offered
11.14.5 Novartis AG (Switzerland) Related Developments
11.15 Novo Nordisk A/S (Denmark)
11.15.1 Novo Nordisk A/S (Denmark) Corporation Information
11.15.2 Novo Nordisk A/S (Denmark) Description and Business Overview
11.15.3 Novo Nordisk A/S (Denmark) Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Novo Nordisk A/S (Denmark) Products Offered
11.15.5 Novo Nordisk A/S (Denmark) Related Developments
11.16 Pfizer, Inc. (USA)
11.16.1 Pfizer, Inc. (USA) Corporation Information
11.16.2 Pfizer, Inc. (USA) Description and Business Overview
11.16.3 Pfizer, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Pfizer, Inc. (USA) Products Offered
11.16.5 Pfizer, Inc. (USA) Related Developments
11.17 Sanofi S.A (France)
11.17.1 Sanofi S.A (France) Corporation Information
11.17.2 Sanofi S.A (France) Description and Business Overview
11.17.3 Sanofi S.A (France) Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Sanofi S.A (France) Products Offered
11.17.5 Sanofi S.A (France) Related Developments
11.18 Shionogi Inc. (USA)
11.18.1 Shionogi Inc. (USA) Corporation Information
11.18.2 Shionogi Inc. (USA) Description and Business Overview
11.18.3 Shionogi Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Shionogi Inc. (USA) Products Offered
11.18.5 Shionogi Inc. (USA) Related Developments
11.19 Takeda
11.19.1 Takeda Corporation Information
11.19.2 Takeda Description and Business Overview
11.19.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Takeda Products Offered
11.19.5 Takeda Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pediatric Drugs and Vaccines Market Estimates and Projections by Region
12.1.1 Global Pediatric Drugs and Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Pediatric Drugs and Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Pediatric Drugs and Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Pediatric Drugs and Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Pediatric Drugs and Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Pediatric Drugs and Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Pediatric Drugs and Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Pediatric Drugs and Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Pediatric Drugs and Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Pediatric Drugs and Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pediatric Drugs and Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pediatric Drugs and Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pediatric Drugs and Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pediatric Drugs and Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Pediatric Drugs and Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Pediatric Drugs and Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Pediatric Drugs and Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Pediatric Drugs and Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pediatric Drugs and Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pediatric Drugs and Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pediatric Drugs and Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pediatric Drugs and Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pediatric Drugs and Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pediatric Drugs and Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Pediatric Drugs and Vaccines Market Segments
Table 2. Ranking of Global Top Pediatric Drugs and Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Diphtheria
Table 5. Major Manufacturers of Influenza
Table 6. Major Manufacturers of Hepatitis
Table 7. Major Manufacturers of Pneumococcal Diseases
Table 8. Major Manufacturers of Meningococcal Diseases
Table 9. Major Manufacturers of Mumps
Table 10. Major Manufacturers of Others
Table 11. Global Pediatric Drugs and Vaccines Market Size Growth Rate by Application 2020-2026 (MT)
Table 12. Global Pediatric Drugs and Vaccines Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 13. Global Pediatric Drugs and Vaccines Sales by Regions 2015-2020 (MT)
Table 14. Global Pediatric Drugs and Vaccines Sales Market Share by Regions (2015-2020)
Table 15. Global Pediatric Drugs and Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Pediatric Drugs and Vaccines Sales by Manufacturers (2015-2020) (MT)
Table 17. Global Pediatric Drugs and Vaccines Sales Share by Manufacturers (2015-2020)
Table 18. Global Pediatric Drugs and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Pediatric Drugs and Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Drugs and Vaccines as of 2019)
Table 20. Pediatric Drugs and Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Pediatric Drugs and Vaccines Price (2015-2020) (USD/Kg)
Table 23. Pediatric Drugs and Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Pediatric Drugs and Vaccines Product Type
Table 25. Date of International Manufacturers Enter into Pediatric Drugs and Vaccines Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Pediatric Drugs and Vaccines Sales by Type (2015-2020) (MT)
Table 28. Global Pediatric Drugs and Vaccines Sales Share by Type (2015-2020)
Table 29. Global Pediatric Drugs and Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Pediatric Drugs and Vaccines Revenue Share by Type (2015-2020)
Table 31. Pediatric Drugs and Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 32. Global Pediatric Drugs and Vaccines Sales by Application (2015-2020) (MT)
Table 33. Global Pediatric Drugs and Vaccines Sales Share by Application (2015-2020)
Table 34. North America Pediatric Drugs and Vaccines Sales by Country (2015-2020) (MT)
Table 35. North America Pediatric Drugs and Vaccines Sales Market Share by Country (2015-2020)
Table 36. North America Pediatric Drugs and Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Pediatric Drugs and Vaccines Revenue Market Share by Country (2015-2020)
Table 38. North America Pediatric Drugs and Vaccines Sales by Type (2015-2020) (MT)
Table 39. North America Pediatric Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 40. North America Pediatric Drugs and Vaccines Sales by Application (2015-2020) (MT)
Table 41. North America Pediatric Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 42. Europe Pediatric Drugs and Vaccines Sales by Country (2015-2020) (MT)
Table 43. Europe Pediatric Drugs and Vaccines Sales Market Share by Country (2015-2020)
Table 44. Europe Pediatric Drugs and Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country (2015-2020)
Table 46. Europe Pediatric Drugs and Vaccines Sales by Type (2015-2020) (MT)
Table 47. Europe Pediatric Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 48. Europe Pediatric Drugs and Vaccines Sales by Application (2015-2020) (MT)
Table 49. Europe Pediatric Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2015-2020) (MT)
Table 51. Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Pediatric Drugs and Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Pediatric Drugs and Vaccines Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Pediatric Drugs and Vaccines Sales by Type (2015-2020) (MT)
Table 55. Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Pediatric Drugs and Vaccines Sales by Application (2015-2020) (MT)
Table 57. Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 58. Latin America Pediatric Drugs and Vaccines Sales by Country (2015-2020) (MT)
Table 59. Latin America Pediatric Drugs and Vaccines Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Pediatric Drugs and Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Pediatric Drugs and Vaccines Revenue Market Share by Country (2015-2020)
Table 62. Latin America Pediatric Drugs and Vaccines Sales by Type (2015-2020) (MT)
Table 63. Latin America Pediatric Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 64. Latin America Pediatric Drugs and Vaccines Sales by Application (2015-2020) (MT)
Table 65. Latin America Pediatric Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2015-2020) (MT)
Table 67. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Pediatric Drugs and Vaccines Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Pediatric Drugs and Vaccines Sales by Type (2015-2020) (MT)
Table 71. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Pediatric Drugs and Vaccines Sales by Application (2015-2020) (MT)
Table 73. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Application (2015-2020)
Table 74. Merck & Co., Inc. (USA) Corporation Information
Table 75. Merck & Co., Inc. (USA) Description and Major Businesses
Table 76. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. Merck & Co., Inc. (USA) Product
Table 78. Merck & Co., Inc. (USA) Recent Development
Table 79. Abbott Laboratories (USA) Corporation Information
Table 80. Abbott Laboratories (USA) Description and Major Businesses
Table 81. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. Abbott Laboratories (USA) Product
Table 83. Abbott Laboratories (USA) Recent Development
Table 84. Amgen, Inc. (USA) Corporation Information
Table 85. Amgen, Inc. (USA) Description and Major Businesses
Table 86. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. Amgen, Inc. (USA) Product
Table 88. Amgen, Inc. (USA) Recent Development
Table 89. Eli Lilly and Company (USA) Corporation Information
Table 90. Eli Lilly and Company (USA) Description and Major Businesses
Table 91. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Eli Lilly and Company (USA) Product
Table 93. Eli Lilly and Company (USA) Recent Development
Table 94. F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
Table 95. F. Hoffmann-La Roche Ltd (Switzerland) Description and Major Businesses
Table 96. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 97. F. Hoffmann-La Roche Ltd (Switzerland) Product
Table 98. F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
Table 99. Genentech, Inc. (USA) Corporation Information
Table 100. Genentech, Inc. (USA) Description and Major Businesses
Table 101. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 102. Genentech, Inc. (USA) Product
Table 103. Genentech, Inc. (USA) Recent Development
Table 104. GlaxoSmithKline plc. (UK) Corporation Information
Table 105. GlaxoSmithKline plc. (UK) Description and Major Businesses
Table 106. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 107. GlaxoSmithKline plc. (UK) Product
Table 108. GlaxoSmithKline plc. (UK) Recent Development
Table 109. Janssen Biologics B.V. (USA) Corporation Information
Table 110. Janssen Biologics B.V. (USA) Description and Major Businesses
Table 111. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Janssen Biologics B.V. (USA) Product
Table 113. Janssen Biologics B.V. (USA) Recent Development
Table 114. Actelion Pharmaceuticals Corporation Information
Table 115. Actelion Pharmaceuticals Description and Major Businesses
Table 116. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Actelion Pharmaceuticals Product
Table 118. Actelion Pharmaceuticals Recent Development
Table 119. AstraZeneca Plc. (UK) Corporation Information
Table 120. AstraZeneca Plc. (UK) Description and Major Businesses
Table 121. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. AstraZeneca Plc. (UK) Product
Table 123. AstraZeneca Plc. (UK) Recent Development
Table 124. Boehringer Ingelheim GmbH (Germany) Corporation Information
Table 125. Boehringer Ingelheim GmbH (Germany) Description and Major Businesses
Table 126. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 127. Boehringer Ingelheim GmbH (Germany) Product
Table 128. Boehringer Ingelheim GmbH (Germany) Recent Development
Table 129. Bristol-Myers Squibb Company (USA) Corporation Information
Table 130. Bristol-Myers Squibb Company (USA) Description and Major Businesses
Table 131. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 132. Bristol-Myers Squibb Company (USA) Product
Table 133. Bristol-Myers Squibb Company (USA) Recent Development
Table 134. Allergan, Inc. (USA) Corporation Information
Table 135. Allergan, Inc. (USA) Description and Major Businesses
Table 136. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 137. Allergan, Inc. (USA) Product
Table 138. Allergan, Inc. (USA) Recent Development
Table 139. Novartis AG (Switzerland) Corporation Information
Table 140. Novartis AG (Switzerland) Description and Major Businesses
Table 141. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 142. Novartis AG (Switzerland) Product
Table 143. Novartis AG (Switzerland) Recent Development
Table 144. Novo Nordisk A/S (Denmark) Corporation Information
Table 145. Novo Nordisk A/S (Denmark) Description and Major Businesses
Table 146. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 147. Novo Nordisk A/S (Denmark) Product
Table 148. Novo Nordisk A/S (Denmark) Recent Development
Table 149. Pfizer, Inc. (USA) Corporation Information
Table 150. Pfizer, Inc. (USA) Description and Major Businesses
Table 151. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 152. Pfizer, Inc. (USA) Product
Table 153. Pfizer, Inc. (USA) Recent Development
Table 154. Sanofi S.A (France) Corporation Information
Table 155. Sanofi S.A (France) Description and Major Businesses
Table 156. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 157. Sanofi S.A (France) Product
Table 158. Sanofi S.A (France) Recent Development
Table 159. Shionogi Inc. (USA) Corporation Information
Table 160. Shionogi Inc. (USA) Description and Major Businesses
Table 161. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 162. Shionogi Inc. (USA) Product
Table 163. Shionogi Inc. (USA) Recent Development
Table 164. Takeda Corporation Information
Table 165. Takeda Description and Major Businesses
Table 166. Takeda Pediatric Drugs and Vaccines Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 167. Takeda Product
Table 168. Takeda Recent Development
Table 169. Global Pediatric Drugs and Vaccines Sales Forecast by Regions (2021-2026) (MT)
Table 170. Global Pediatric Drugs and Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 171. Global Pediatric Drugs and Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 172. Global Pediatric Drugs and Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 173. North America: Pediatric Drugs and Vaccines Sales Forecast by Country (2021-2026) (MT)
Table 174. North America: Pediatric Drugs and Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 175. Europe: Pediatric Drugs and Vaccines Sales Forecast by Country (2021-2026) (MT)
Table 176. Europe: Pediatric Drugs and Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 177. Asia Pacific: Pediatric Drugs and Vaccines Sales Forecast by Region (2021-2026) (MT)
Table 178. Asia Pacific: Pediatric Drugs and Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 179. Latin America: Pediatric Drugs and Vaccines Sales Forecast by Country (2021-2026) (MT)
Table 180. Latin America: Pediatric Drugs and Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 181. Middle East and Africa: Pediatric Drugs and Vaccines Sales Forecast by Country (2021-2026) (MT)
Table 182. Middle East and Africa: Pediatric Drugs and Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 183. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 184. Key Challenges
Table 185. Market Risks
Table 186. Main Points Interviewed from Key Pediatric Drugs and Vaccines Players
Table 187. Pediatric Drugs and Vaccines Customers List
Table 188. Pediatric Drugs and Vaccines Distributors List
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Pediatric Drugs and Vaccines Product Picture
Figure 2. Global Pediatric Drugs and Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Diphtheria Product Picture
Figure 4. Influenza Product Picture
Figure 5. Hepatitis Product Picture
Figure 6. Pneumococcal Diseases Product Picture
Figure 7. Meningococcal Diseases Product Picture
Figure 8. Mumps Product Picture
Figure 9. Others Product Picture
Figure 10. Global Pediatric Drugs and Vaccines Sales Market Share by Application in 2020 & 2026
Figure 11. Newborn
Figure 12. Infant
Figure 13. Child
Figure 14. Pediatric Drugs and Vaccines Report Years Considered
Figure 15. Global Pediatric Drugs and Vaccines Market Size 2015-2026 (US$ Million)
Figure 16. Global Pediatric Drugs and Vaccines Sales 2015-2026 (MT)
Figure 17. Global Pediatric Drugs and Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2015-2020)
Figure 19. Global Pediatric Drugs and Vaccines Sales Market Share by Region in 2019
Figure 20. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2015-2020)
Figure 21. Global Pediatric Drugs and Vaccines Revenue Market Share by Region in 2019
Figure 22. Global Pediatric Drugs and Vaccines Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Pediatric Drugs and Vaccines Revenue in 2019
Figure 24. Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2015-2020)
Figure 26. Global Pediatric Drugs and Vaccines Sales Market Share by Type in 2019
Figure 27. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2015-2020)
Figure 28. Global Pediatric Drugs and Vaccines Revenue Market Share by Type in 2019
Figure 29. Global Pediatric Drugs and Vaccines Market Share by Price Range (2015-2020)
Figure 30. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2015-2020)
Figure 31. Global Pediatric Drugs and Vaccines Sales Market Share by Application in 2019
Figure 32. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2015-2020)
Figure 33. Global Pediatric Drugs and Vaccines Revenue Market Share by Application in 2019
Figure 34. North America Pediatric Drugs and Vaccines Sales Growth Rate 2015-2020 (MT)
Figure 35. North America Pediatric Drugs and Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Pediatric Drugs and Vaccines Sales Market Share by Country in 2019
Figure 37. North America Pediatric Drugs and Vaccines Revenue Market Share by Country in 2019
Figure 38. U.S. Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 39. U.S. Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 41. Canada Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Pediatric Drugs and Vaccines Market Share by Type in 2019
Figure 43. North America Pediatric Drugs and Vaccines Market Share by Application in 2019
Figure 44. Europe Pediatric Drugs and Vaccines Sales Growth Rate 2015-2020 (MT)
Figure 45. Europe Pediatric Drugs and Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Pediatric Drugs and Vaccines Sales Market Share by Country in 2019
Figure 47. Europe Pediatric Drugs and Vaccines Revenue Market Share by Country in 2019
Figure 48. Germany Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 49. Germany Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 51. France Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 53. U.K. Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 55. Italy Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 57. Russia Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Pediatric Drugs and Vaccines Market Share by Type in 2019
Figure 59. Europe Pediatric Drugs and Vaccines Market Share by Application in 2019
Figure 60. Asia Pacific Pediatric Drugs and Vaccines Sales Growth Rate 2015-2020 (MT)
Figure 61. Asia Pacific Pediatric Drugs and Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Region in 2019
Figure 63. Asia Pacific Pediatric Drugs and Vaccines Revenue Market Share by Region in 2019
Figure 64. China Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 65. China Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 67. Japan Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 69. South Korea Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 71. India Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 73. Australia Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 75. Taiwan Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 77. Indonesia Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 79. Thailand Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 81. Malaysia Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 83. Philippines Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 85. Vietnam Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Pediatric Drugs and Vaccines Market Share by Type in 2019
Figure 87. Asia Pacific Pediatric Drugs and Vaccines Market Share by Application in 2019
Figure 88. Latin America Pediatric Drugs and Vaccines Sales Growth Rate 2015-2020 (MT)
Figure 89. Latin America Pediatric Drugs and Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Pediatric Drugs and Vaccines Sales Market Share by Country in 2019
Figure 91. Latin America Pediatric Drugs and Vaccines Revenue Market Share by Country in 2019
Figure 92. Mexico Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 93. Mexico Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 95. Brazil Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 97. Argentina Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Pediatric Drugs and Vaccines Market Share by Type in 2019
Figure 99. Latin America Pediatric Drugs and Vaccines Market Share by Application in 2019
Figure 100. Middle East and Africa Pediatric Drugs and Vaccines Sales Growth Rate 2015-2020 (MT)
Figure 101. Middle East and Africa Pediatric Drugs and Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Pediatric Drugs and Vaccines Revenue Market Share by Country in 2019
Figure 104. Turkey Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 105. Turkey Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 107. Saudi Arabia Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Pediatric Drugs and Vaccines Sales Growth Rate (2015-2020) (MT)
Figure 109. U.A.E Pediatric Drugs and Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Pediatric Drugs and Vaccines Market Share by Type in 2019
Figure 111. Middle East and Africa Pediatric Drugs and Vaccines Market Share by Application in 2019
Figure 112. North America Pediatric Drugs and Vaccines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 113. North America Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Pediatric Drugs and Vaccines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 115. Europe Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Pediatric Drugs and Vaccines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 117. Asia Pacific Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Pediatric Drugs and Vaccines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 119. Latin America Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Pediatric Drugs and Vaccines Sales Growth Rate Forecast (2021-2026) (MT)
Figure 121. Middle East and Africa Pediatric Drugs and Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
小児用ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Pediatric Vaccines Market The global Pediatric Vaccines market size is projected to reach US$ 30650 million by 2026, from US$ 28880 million in 2020, at a CAGR of 5.7%% during 2021-2026. Global Pediatric Vaccines Scope and Market Size Pediatric Vaccines market is …- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- 小児放射線の世界市場（～2026年） Pediatric radiology is a subspecialty of radiology involving the imaging of fetuses, infants, children, adolescents and young adults. The key factor contributing to the pediatric radiology market is the increasing incidence of diagnosis. Market Analysis and Insights: Global Pediatric Radiology Marke…
- 髄膜炎菌ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Meningococcal Vaccines Market The global Meningococcal Vaccines market size is projected to reach US$ 250.5 million by 2026, from US$ 239 million in 2020, at a CAGR of 4.4%% during 2021-2026. Global Meningococcal Vaccines Scope and Market Size Meningococcal Vacci…
- 小児神経芽細胞腫治療の世界市場（～2026年） In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017. Market Analysis and Insights: Global Pediatric Neuroblastoma Treatment Market The global Pediatric Neuroblastoma Treatment market size is…